Bayer can’t dismiss Essure injuries as ‘common women’s symptoms’, class action trial told
Pharmaceutical giant Bayer cannot write off debilitating chronic pain and bleeding which patients allegedly experienced after being implanted with Essure contraceptives as “common women’s symptoms”, a court has heard in the first day of trial in a long-running class action.
For information on rights and reprints, contact subscriptions@lawyerly.com.au